drugset / Trial / NCT00159809

Efficacy Study Measuring The Impact Of Treatment With Viagra On The Depressive Symptoms Of Men With Erectile Dysfunction

NCT00159809

Phase 4 Completed 140 enrolled Viatris Inc. Pfizer · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will measure the impact of treatment with Viagra on the depressive symptoms and quality of life in men with erectile dysfunction who have untreated depressive symptoms meeting the DSM-IV criteria for dysthymia or depression not otherwise specified (NOS), including minor depressive symptoms but excluding any form of psychotic disorder.

Timeline

Start
2004-03
Primary completion
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown